These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24172809)

  • 21. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.
    Aykanat A; Yavuz T; Özalkaya E; Topçuoğlu S; Ovalı F; Karatekin G
    Pediatr Cardiol; 2016 Jan; 37(1):131-4. PubMed ID: 26260095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandins and the management of congenital heart disease.
    Taylor WJ; Alpert BS
    Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nursing care of neonates receiving intravenous prostaglandin E1 therapy who are not in an intensive care unit.
    Hudspeth R; O'Toole E
    Crit Care Nurse; 2000 Jun; 20(3):62-8. PubMed ID: 11876215
    [No Abstract]   [Full Text] [Related]  

  • 24. [Skeletal side effects of treatment with prostaglandin E1].
    Persigehl M; Hövels-Gürich H; von Bernuth G
    Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fate of the "opened" arterial duct: Lessons learned from bilateral pulmonary artery banding for hypoplastic left heart syndrome under the continuous infusion of prostaglandin E1.
    Mitani Y; Takabayashi S; Sawada H; Ohashi H; Hayakawa H; Ikeyama Y; Imanaka-Yoshida K; Maruyama K; Shimpo H; Komada Y
    J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1653-4. PubMed ID: 17532977
    [No Abstract]   [Full Text] [Related]  

  • 26. Neonatal transport issues with prostaglandin E1 infusions.
    Grubbs TC; Kraft NL
    Air Med J; 2002; 21(3):8-12. PubMed ID: 11994726
    [No Abstract]   [Full Text] [Related]  

  • 27. Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates.
    Høst A; Halken S; Kamper J; Lillquist K
    Dan Med Bull; 1988 Feb; 35(1):81-4. PubMed ID: 3342648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology of the arterial duct (ductus arteriosus) with and without treatment with prostaglandin E1.
    Gittenberger-de Groot AC; Strengers JL
    Int J Cardiol; 1988 May; 19(2):153-66. PubMed ID: 3372078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.
    Reddy SC; Saxena A
    Indian J Pediatr; 1998; 65(2):211-6. PubMed ID: 10771966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous prostaglandin E1 (alprostadil) bolus in ductus arteriosus-dependent CHD: valid or absolutely contraindicated?
    Colín Ortiz JL; Cruz Hernández A; Silva Estrada JA; Maldonado Alonso R; Corona Villalobos CA; González Rebeles Guerrero C; Pérez Pérez LF
    Cardiol Young; 2024 Feb; 34(2):314-318. PubMed ID: 37403735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.
    Leonhardt A; Schweer H; Wolf D; Seyberth HW
    Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ductus arteriosus: why and how to manipulate its patency.
    Drummond WH; Bucciarelli RL; Gessner IH
    J Fla Med Assoc; 1983 Sep; 70(9):788-93. PubMed ID: 6355376
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastric outlet obstruction after long-term prostaglandin administration mimicking hypertrophic pyloric stenosis.
    Lacher M; Schneider K; Dalla Pozza R; Schweinitz DV
    Eur J Pediatr Surg; 2007 Oct; 17(5):362-4. PubMed ID: 17968795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stent implantation in the arterial duct of the newborn with duct-dependent pulmonary circulation: single centre experience from Turkey.
    Odemis E; Haydin S; Guzeltas A; Ozyilmaz I; Bilici M; Bakir I
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):57-60. PubMed ID: 22290915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications of Long-Term Prostaglandin E1 Use in Newborns With Ductal-Dependent Critical Congenital Heart Disease.
    Alhussin W; Verklan MT
    J Perinat Neonatal Nurs; 2016; 30(1):73-9. PubMed ID: 26813395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin-induced hyperostosis. A case report.
    Drvaric DM; Parks WJ; Wyly JB; Dooley KJ; Plauth WH; Schmitt EW
    Clin Orthop Relat Res; 1989 Sep; (246):300-4. PubMed ID: 2766619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Operative closure of patent ductus arteriosus in the neonatal intensive care unit.
    Mortier E; Ongenae M; Vermassen F; Van Aken J; De Roose J; Van Haesebrouck P; Vandeveire B; Rolly G
    Acta Chir Belg; 1996; 96(6):266-8. PubMed ID: 9008767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies].
    Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G
    Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760
    [No Abstract]   [Full Text] [Related]  

  • 40. Alprostadil (Prostin VR Pediatric Sterile Solution, The Upjohn Company).
    Roehl SL; Townsend RJ
    Drug Intell Clin Pharm; 1982 Nov; 16(11):823-32. PubMed ID: 6756848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.